Pemetrexed Plus Bevacizumab for Second-Line Therapy of Non-Small-Cell Lung Cancer: The Importance of Patient Selection
AuthID
P-003-8B2
P-003-8B2
© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service